SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Raymond James Maintains Strong Buy on NGM Biopharmaceuticals, Raises Price Target to $32

Raymond James maintains NGM Biopharmaceuticals (NASDAQ:NGM) with a Strong Buy and raises the price target from $31 to $32.

Benzinga · 05/14/2020 11:29

Raymond James maintains NGM Biopharmaceuticals (NASDAQ:NGM) with a Strong Buy and raises the price target from $31 to $32.